257 |
Antiplatelets Only Sufficient: TAVR Antithrombotics Less is More |
George D. Dangas |
Apr. 12. 21 |
256 |
Transcatheter Mitral Valve Repair: Guideline Changes, Evidence Gaps and Future Directions |
Gregg W. Stone |
Apr. 12. 21 |
255 |
TAVR Long Journey: Chain of RCTs, Guideline Changes, and Future Directions |
Martin Bert Leon |
Apr. 12. 21 |
254 |
Functional MR - Percutaneous Treatment Considerations |
Samir R. Kapadia |
Apr. 12. 21 |
253 |
Coronary Access Post TAVI |
Danny Dvir |
Apr. 12. 21 |
252 |
Minimizing Embolic Events: Latest TAVR Data |
Eberhard Grube |
Apr. 12. 21 |
251 |
Durability of Balloon-Expandable Transcatheter Heart Valve |
Alain G. Cribier |
Apr. 27. 19 |
250 |
Sapien 3 THV with Future Coronary Access |
Alan C. Yeung |
Apr. 27. 19 |
249 |
Current Status of Balloon-Expandable TAVR in Korea |
Jung-Min Ahn |
Apr. 27. 19 |
248 |
Global Update : Low-Risk TAVR |
Vinayak Bapat |
Apr. 27. 19 |